Great Basin Scientific (Great Basin Scientific) Debt-to-Equity : -1.12 (As of Mar. 2017)

View and export this data going back to 2014. Start your Free Trial

What is Great Basin Scientific Debt-to-Equity?

Great Basin Scientific's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2017 was $33.25 Mil. Great Basin Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2017 was $0.05 Mil. Great Basin Scientific's Total Stockholders Equity for the quarter that ended in Mar. 2017 was $-29.86 Mil. Great Basin Scientific's debt to equity for the quarter that ended in Mar. 2017 was -1.12.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Great Basin Scientific's Debt-to-Equity or its related term are showing as below:

GBSNQ's Debt-to-Equity is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 0.22
* Ranked among companies with meaningful Debt-to-Equity only.

Great Basin Scientific Debt-to-Equity Historical Data

The historical data trend for Great Basin Scientific's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Basin Scientific Debt-to-Equity Chart

Great Basin Scientific Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Debt-to-Equity

-0.01

-0.08

-0.40

-0.92

-1.37

Great Basin Scientific Quarterly Data
	Dec12	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Debt-to-Equity	Get a 7-Day Free Trial												-0.25	-0.26	-0.47	-1.37	-1.12

Competitive Comparison of Great Basin Scientific's Debt-to-Equity

For the Diagnostics & Research subindustry, Great Basin Scientific's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Great Basin Scientific's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Great Basin Scientific's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Great Basin Scientific's Debt-to-Equity falls into.

Great Basin Scientific Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Great Basin Scientific's Debt to Equity Ratio for the fiscal year that ended in Dec. 2016 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(61.365	+	15.056)	/	-55.986
	=	-1.37

Great Basin Scientific's Debt to Equity Ratio for the quarter that ended in Mar. 2017 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(33.246	+	0.052)	/	-29.861
	=	-1.12

Great Basin Scientific (GREY:GBSNQ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Great Basin Scientific Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Great Basin Scientific's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Basin Scientific (Great Basin Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Great Basin Scientific Inc (GREY:GBSNQ) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 East South Temple, Suite 520, Salt Lake City, UT, USA, 84111

Website

http://www.gbscience.com

Great Basin Scientific Inc is the United States based molecular diagnostic testing company. It is focused on the development and commercialization of molecular diagnostic platform designed to test for the infectious disease, especially hospital-acquired infections. Molecular diagnostic testing reduces test time from days to hours compared to culture methods. The company's system includes an analyzer, which it provides for the customers' use without charge in the United States, and a diagnostic cartridge, which it sells to the customers. The group derives its revenue from the sale of single-use assays sold in the United States, the European Union, and New Zealand, of which majority of the revenue is generated from the United States.

Great Basin Scientific (Great Basin Scientific) Headlines

No Headlines